VC
Vivo Capital Portfolio holdings
AUM
$977M
This Quarter Return
+55.69%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$1.22B
AUM Growth
+$1.22B
(+34%)
Cap. Flow
+$15.8M
Cap. Flow
% of AUM
1.3%
Top 10 Holdings %
Top 10 Hldgs %
72.94%
Holding
57
New
4
Increased
6
Reduced
10
Closed
10
Top Buys
| 1 |
Soleno Therapeutics
SLNO
|
$210M |
| 2 |
Geron
GERN
|
$16.1M |
| 3 |
Tourmaline Bio
TRML
|
$15.5M |
| 4 |
SLN
Silence Therapeutics
SLN
|
$8.86M |
| 5 |
Pharvaris
PHVS
|
$7.99M |
Top Sells
| 1 |
Instil Bio
TIL
|
$90.4M |
| 2 |
SVA
Sinovac Biotech, Ltd
SVA
|
$38.2M |
| 3 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
$32.5M |
| 4 |
GTH
Genetron Holdings Limited ADS
GTH
|
$19.9M |
| 5 |
Arcellx
ACLX
|
$18.1M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Consumer Staples | 0% |
| 3 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Soleno Therapeutics
SLNO
$3.6B
| $339M | 27.74% | 8,418,093 +5,215,000 | +163% | +$210M |
|
|
GRCL
2
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $95.8M | 7.85% | 9,546,485 -1,334,659 | -12% | -$13.4M |
|
|
VRNA
3
Verona Pharma
VRNA
$9.16B
| $84.5M | 6.92% | 4,249,918 | – | – |
|
4
Harmony Biosciences
HRMY
$2.12B
| $84.2M | 6.89% | 2,606,247 | – | – |
|
5
ALX Oncology
ALXO
$62.7M
| $62.8M | 5.14% | 4,220,048 | – | – |
|
|
AVDL
6
Avadel Pharmaceuticals
AVDL
$1.43B
| $57.8M | 4.74% | 4,096,428 | – | – |
|
|
7
Geron
GERN
$893M
| $50.9M | 4.17% | 24,143,681 +7,619,047 | +46% | +$16.1M |
|
8
Terns Pharmaceuticals
TERN
$609M
| $43.2M | 3.54% | 6,657,992 | – | – |
|
9
Viridian Therapeutics
VRDN
$1.5B
| $36.6M | 2.99% | 1,678,207 | – | – |
|
10
Tarsus Pharmaceuticals
TARS
$2.47B
| $36.1M | 2.96% | 1,784,006 -478,194 | -21% | -$9.68M |
|
|
ICVX
11
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $26.9M | 2.2% | 1,704,568 | – | – |
|
12
Olema Pharmaceuticals
OLMA
$375M
| $26.3M | 2.15% | 1,873,704 | – | – |
|
13
Astria Therapeutics
ATXS
$349M
| $19.1M | 1.56% | 2,482,727 +801,528 | +48% | +$6.16M |
|
|
ALPN
14
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $15.6M | 1.28% | 819,275 -95,638 | -10% | -$1.82M |
|
|
15
Tourmaline Bio
TRML
$601M
| $15.5M | 1.27% | +591,882 | New | +$15.5M |
|
|
CMPS
16
Compass Pathways
CMPS
$424M
| $14.1M | 1.15% | 1,608,000 | – | – |
|
17
Dyne Therapeutics
DYN
$1.92B
| $13.8M | 1.13% | 1,035,136 | – | – |
|
18
Cogent Biosciences
COGT
$1.69B
| $13.2M | 1.08% | 2,244,941 | – | – |
|
19
Verastem
VSTM
$569M
| $12.5M | 1.03% | 1,538,461 | – | – |
|
20
Crinetics Pharmaceuticals
CRNX
$2.92B
| $12.5M | 1.02% | 350,000 | – | – |
|
21
IO Biotech
IOBT
$104M
| $11.6M | 0.95% | 6,173,439 | – | – |
|
22
Zai Lab
ZLAB
$3.68B
| $11.3M | 0.92% | 411,677 -42,929 | -9% | -$1.17M |
|
23
Apogee Therapeutics
APGE
$2.17B
| $11.2M | 0.92% | 400,000 | – | – |
|
24
KalVista Pharmaceuticals
KALV
$678M
| $10.5M | 0.86% | 856,008 | – | – |
|
|
GTH
25
DELISTED
Genetron Holdings Limited ADS
GTH
| $9.97M | 0.82% | 2,708,056 -5,416,118 | -67% | -$19.9M |
|